Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Transverses Abdominis -Plane Block With Bupivacaine Versus Bupivacaine With Morphine Postoperatively

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 60 ASA I-II cancer patients with age range (18-60) years,~* weight (50- 85) kg~Exclusion Criteria:~* with patients with known drug allergy to study drugs~* with significant cardiac, respiratory, renal or hepatic disease~* with coagulation disorders~* those with psychiatric illnesses that would interfere with perception and assessment of pain.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- TAP with bupivicaine (Type: PLACEBO_COMPARATOR): 30 patients receive ultrasound guided transversus abdominis-plane block (TAP) with local anesthetic 20 ml of bupivacaine 0.5 % diluted in 20 ml saline (total volume 40 ml) in two divided doses i.e. 20 ml is administered on each side of the abdominal wall.
- TAP with bupivicaine with morphine (Type: ACTIVE_COMPARATOR): 30 patients receive ultrasound guided transversus abdominis-plane block (TAP) with local anesthetic 20 ml of bupivacaine 0.5% + 10 mg morphine diluted in 20 ml saline (total volume 40 ml) in two divided doses i.e. 20 ml is administered on each side of the abdominal wall.

Based on this trial design, predict the completion outcome and termination type (if applicable).